BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32176061)

  • 21. Apatinib Monotherapy or Combination Therapy for Non-Small Cell Lung Cancer Patients With Brain Metastases.
    Xu J; Liu X; Yang S; Shi Y
    Oncol Res; 2020 Mar; 28(2):127-133. PubMed ID: 31610827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Definitive concurrent chemoradiotherapy in cervical cancer--a University of Malaya Medical Centre experience.
    Zamaniah WI; Mastura MY; Phua CE; Adlinda A; Marniza S; Rozita AM
    Asian Pac J Cancer Prev; 2014; 15(20):8987-92. PubMed ID: 25374241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical Trial.
    Shrivastava S; Mahantshetty U; Engineer R; Chopra S; Hawaldar R; Hande V; Kerkar RA; Maheshwari A; Shylasree TS; Ghosh J; Bajpai J; Gurram L; Gulia S; Gupta S;
    JAMA Oncol; 2018 Apr; 4(4):506-513. PubMed ID: 29423520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of clinical efficacy of three different neoadjuvant approaches (chemotherapy combined vaginal intracavitary irradiation, neoadjuvant chemotherapy alone or radiotherapy) combined with surgery for patients with stage Ib2 and IIa2 cervical cancer.
    Fu JH; Gao Z; Ren CC; Shi YG
    Asian Pac J Cancer Prev; 2013; 14(4):2377-81. PubMed ID: 23725144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix.
    Eralp Y; Saip P; Sakar B; Kucucuk S; Aydiner A; Dincer M; Aslay I; Topuz E
    Int J Gynecol Cancer; 2003; 13(4):497-504. PubMed ID: 12911727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective randomized controlled study on multiple neoadjuvant treatments for patients with stage IB2 to IIA cervical cancer.
    Wen H; Wu X; Li Z; Wang H; Zang R; Sun M; Huang X; Zhang Z; Cai S
    Int J Gynecol Cancer; 2012 Feb; 22(2):296-302. PubMed ID: 22274319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase 2 Randomized Controlled Trial of Radiation Therapy Plus Concurrent Interferon-Alpha and Retinoic Acid Versus Cisplatin for Stage III Cervical Carcinoma.
    Basu P; Jenson AB; Majhi T; Choudhury P; Mandal R; Banerjee D; Biswas J; Pan J; Rai SN; Ghim SJ; Miller D
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):102-110. PubMed ID: 26700705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Efficacy And Safety Of Apatinib Treatment For Patients With Metastatic Or Recurrent Cervical Cancer: A Retrospective Study.
    Yu J; Xu Z; Li A; Zhang J; Wang Y; Zhao H; Zhu H
    Drug Des Devel Ther; 2019; 13():3419-3424. PubMed ID: 31576114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial.
    Chen J; Li C; Cao Y; Zhu L; Zhang B; You J; Hou H; Wang J; Yuan Z
    BMC Cancer; 2022 Jul; 22(1):793. PubMed ID: 35854236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance imaging after external beam radiotherapy and concurrent chemotherapy for locally advanced cervical cancer helps to identify patients at risk of recurrence.
    Angeles MA; Baissas P; Leblanc E; Lusque A; Ferron G; Ducassou A; Martínez-Gómez C; Querleu D; Martinez A
    Int J Gynecol Cancer; 2019 Mar; 29(3):480-486. PubMed ID: 30712019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Safety and Efficacy of Apatinib Treatment in Addition to Concurrent Chemoradiotherapy in Patients with Nonoperative Locally Advanced Esophageal Squamous Cell Carcinoma.
    Hu L; Kong Z; Meng Q; Wang J; Zhou M; Yu J; Jiang X
    Med Sci Monit; 2020 Nov; 26():e927221. PubMed ID: 33243967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of progression-free survival and response to paclitaxel plus carboplatin in patients with recurrent or advanced cervical cancer.
    Hisamatsu T; Mabuchi S; Yoshino K; Fujita M; Enomoto T; Hamasaki T; Kimura T
    Int J Gynecol Cancer; 2012 May; 22(4):623-9. PubMed ID: 22343974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1).
    Macchia G; Ferrandina G; Legge F; Deodato F; Ruggieri V; Lorusso D; Padula GD; Valentini V; Cellini N; Scambia G; Morganti AG
    Am J Clin Oncol; 2010 Dec; 33(6):577-82. PubMed ID: 20023568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
    Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
    BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for pelvic and distant recurrence in locally advanced cervical cancer.
    Queiroz ACM; Fabri V; Mantoan H; Sanches SM; Guimarães APG; Ribeiro ARG; da Nogueira Silveira Lima JP; Chen MJ; Baiocchi G; da Costa AABA
    Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():6-12. PubMed ID: 30771718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of uterine arterial chemoembolization and uterine arterial infusion chemotherapy for advanced cervical cancer before radical radiotherapy: a long-term follow-up study.
    Tian ZZ; Li S; Wang Y; Yue YJ; Zhu XH; Zhao R; Zhang CL; Wei SH
    Arch Gynecol Obstet; 2014 Jul; 290(1):155-62. PubMed ID: 24573504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first-line treatment of advanced esophageal squamous cell carcinoma.
    Zhang B; Qi L; Wang X; Xu J; Liu Y; Mu L; Wang X; Bai L; Huang J
    Cancer Commun (Lond); 2020 Dec; 40(12):711-720. PubMed ID: 33314747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial.
    Lan C; Shen J; Wang Y; Li J; Liu Z; He M; Cao X; Ling J; Huang J; Zheng M; Zou G; Yan H; Liu Q; Yang F; Wei W; Deng Y; Xiong Y; Huang X
    J Clin Oncol; 2020 Dec; 38(34):4095-4106. PubMed ID: 33052760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective phase I-II trial of helical tomotherapy with or without chemotherapy for postoperative cervical cancer patients.
    Schwarz JK; Wahab S; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1258-63. PubMed ID: 20932657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.